Detalles de la búsqueda
1.
Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium.
Tumour Biol
; 37(9): 12329-12337, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297669
2.
Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations.
Blood
; 114(19): 4138-41, 2009 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-19738030
3.
The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns.
Epigenetics
; 8(11): 1226-35, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24071829
4.
Epigenetic quantification of tumor-infiltrating T-lymphocytes.
Epigenetics
; 6(2): 236-46, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20962591
5.
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.
Cancer Res
; 69(2): 599-608, 2009 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19147574
6.
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.
Eur J Immunol
; 37(9): 2378-89, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17694575
7.
DNA methylation analysis as a tool for cell typing.
Epigenetics
; 1(1): 55-60, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17998806
8.
Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex.
Genes Dev
; 16(11): 1397-411, 2002 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12050117
Resultados
1 -
8
de 8
1
Próxima >
>>